Announcements Trials
Browse Landscape

Status

Completed 9Unknown 2Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 138Neoplasms 134Lung Neoplasms 68Prostatic Neoplasms 67Carcinoma, Non-Small-Cell Lung 58Colorectal Neoplasms 45Multiple Myeloma 37Pancreatic Neoplasms 33Melanoma 32Head and Neck Neoplasms 30Brain Neoplasms 30Neoplasm Metastasis 28Ovarian Neoplasms 27Liver Neoplasms 27Carcinoma, Hepatocellular 27Leukemia, Myeloid, Acute 25Colonic Neoplasms 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma 20Leukemia, Lymphocytic, Chronic, B-Cell 20Esophageal Neoplasms 20Carcinoma, Renal Cell 20Lymphoma, Non-Hodgkin 19Urinary Bladder Neoplasms 18Stomach Neoplasms 18Glioblastoma 18Uterine Cervical Neoplasms 17Sarcoma 17Lymphoma, Follicular 17Lymphoma, Large B-Cell, Diffuse 16

Interventions

Varenicline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Observational × Tobacco Use Disorder × Clear all
NCT01532232 2015-12-23

Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)

Memorial Sloan Kettering Cancer Center

Terminated
7 enrolled
Breast

Breast Neoplasms, Tobacco Use Disorder, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡